Australia: Marinova Triples Manufacturing Capacity in Response to “Rapidly Increasing” Global Demand for Fucoidan
Marinova, an Australian biotech focused on the research, development and production of of high purity fucoidan compounds (for information on this ingredient see below), recently completed an AUD $5 million expansion to its state-of-the-art fucoidan extraction facility. Marinova says it supplies fucoidan extracts to leading nutritional and personal care brands in more than 35 countries and that the ingredient is particularly popular in formulations targeting immune support, gut and digestive health, and healthy aging. The company produces Maritech® organic fucoidan, which it claims is the world’s only high-purity, certified organic fucoidan with global regulatory acceptance. “Marinova’s branded Maritech® range is the world’s only high purity, certified organic fucoidan with global regulatory acceptance,” says CEO Paul Garrott. “Natural, clinically proven and sustainably sourced, they are ingredients …